Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.

General overview of radioimmunotherapy of solid tumors.

Navarro-Teulon I, Lozza C, Pèlegrin A, Vivès E, Pouget JP.

Immunotherapy. 2013 May;5(5):467-87. doi: 10.2217/imt.13.34. Review.

PMID:
23638743
2.

Antibody-guided radiation therapy of cancer.

Koppe MJ, Postema EJ, Aarts F, Oyen WJ, Bleichrodt RP, Boerman OC.

Cancer Metastasis Rev. 2005 Dec;24(4):539-67. Review.

PMID:
16408161
3.

Clinical radioimmunotherapy--the role of radiobiology.

Pouget JP, Navarro-Teulon I, Bardiès M, Chouin N, Cartron G, Pèlegrin A, Azria D.

Nat Rev Clin Oncol. 2011 Nov 8;8(12):720-34. doi: 10.1038/nrclinonc.2011.160. Review.

PMID:
22064461
4.

Clinical radioimmunotherapy.

Knox SJ, Meredith RF.

Semin Radiat Oncol. 2000 Apr;10(2):73-93. Review.

PMID:
10727597
5.

Radioimmunotherapy of solid tumors: searching for the right target.

Song H, Sgouros G.

Curr Drug Deliv. 2011 Jan;8(1):26-44. Review.

6.

Radioimmunotherapy for model B cell malignancies using 90Y-labeled anti-CD19 and anti-CD20 monoclonal antibodies.

Ma D, McDevitt MR, Barendswaard E, Lai L, Curcio MJ, Pellegrini V, Brechbiel MW, Scheinberg DA.

Leukemia. 2002 Jan;16(1):60-6.

7.

Current concepts and future directions in radioimmunotherapy.

Lin FI, Iagaru A.

Curr Drug Discov Technol. 2010 Dec;7(4):253-62. Review.

PMID:
21034409
8.

Radioimmunotherapy: a specific treatment protocol for cancer by cytotoxic radioisotopes conjugated to antibodies.

Kawashima H.

ScientificWorldJournal. 2014;2014:492061. doi: 10.1155/2014/492061. Epub 2014 Oct 14. Review.

9.

Status of radioimmunotherapy in the new millennium.

Imam SK.

Cancer Biother Radiopharm. 2001 Jun;16(3):237-56. Review.

PMID:
11471488
10.

A review of human anti-globulin antibody (HAGA, HAMA, HACA, HAHA) responses to monoclonal antibodies. Not four letter words.

Mirick GR, Bradt BM, Denardo SJ, Denardo GL.

Q J Nucl Med Mol Imaging. 2004 Dec;48(4):251-7. Review.

11.

Antibody-based targeted radiation to pediatric tumors.

Modak S, Cheung NK.

J Nucl Med. 2005 Jan;46 Suppl 1:157S-63S. Review.

12.

Radioimmunotherapy: Principles, current trends and future directions.

Karagiannis TC.

Hell J Nucl Med. 2004 Jan-Apr;7(1):39-43.

PMID:
16868640
13.

Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin's lymphoma (NHL).

Weiden PL, Breitz HB.

Crit Rev Oncol Hematol. 2001 Oct;40(1):37-51.

PMID:
11578915
14.

Radioimmunotherapy and colorectal cancer.

Koppe MJ, Bleichrodt RP, Oyen WJ, Boerman OC.

Br J Surg. 2005 Mar;92(3):264-76. Review.

PMID:
15739250
15.

Radionuclide therapy of cancer with radiolabeled antibodies.

Boerman OC, Koppe MJ, Postema EJ, Corstens FH, Oyen WJ.

Anticancer Agents Med Chem. 2007 May;7(3):335-43. Review.

PMID:
17504159
16.

Emerging trends for radioimmunotherapy in solid tumors.

Jain M, Gupta S, Kaur S, Ponnusamy MP, Batra SK.

Cancer Biother Radiopharm. 2013 Nov;28(9):639-50. doi: 10.1089/cbr.2013.1523. Epub 2013 Jul 11. Review.

17.

Treatment of non-Hodgkin's lymphoma (NHL) with radiolabeled antibodies (mAbs).

DeNardo GL.

Semin Nucl Med. 2005 Jul;35(3):202-11.

PMID:
16098294
18.

Strategies for developing effective radioimmunotherapy for solid tumors.

DeNardo GL, O'Donnell RT, Kroger LA, Richman CM, Goldstein DS, Shen S, DeNardo SJ.

Clin Cancer Res. 1999 Oct;5(10 Suppl):3219s-3223s. Review.

PMID:
10541367
19.

Preclinical evaluation of 90Y-labeled anti-CD20 monoclonal antibody for treatment of non-Hodgkin's lymphoma.

Chinn PC, Leonard JE, Rosenberg J, Hanna N, Anderson DR.

Int J Oncol. 1999 Nov;15(5):1017-25.

PMID:
10536187
20.

Current status of cancer therapy with radiolabeled monoclonal antibody.

Oriuchi N, Higuchi T, Hanaoka H, Iida Y, Endo K.

Ann Nucl Med. 2005 Jul;19(5):355-65. Review.

PMID:
16164191

Supplemental Content

Support Center